Special Issue "Novel Diagnostic Technologies for Emerging Viruses"
Deadline for manuscript submissions: 30 November 2021.
Interests: virus heamorrhagic fever; emerging viruses; filovirus; vector-borne viruses; molecular diagnostics; epidemiology; virus genomics; next-generation sequencing
Interests: cancer; biomarkers; infeccious diseases; point-of-care
In the last decade, there has been massive and borderless viral disease outbreaks caused by Ebola virus, Zika virus, and SARS-CoV-2. It is highly likely that this trend will continue, and it is undeniable that a new global epidemic will occur in the near future. In the situation of COVID-19, a very large number of people have been tested to confirm virus infection, and genetic variants that could enhance the transmission of the virus have emerged. In order to overcome this situation, cost-effective, labor-saving, high-throughput molecular diagnostic technologies for detecting viruses and their genetic mutations need to be continuously developed. Furthermore, surveillance of zoonotic viruses is also necessary in the preparedness for the next spillover of known or unknown pathogenic viruses from nature to human communities. In this Special Issue, we focus on novel and effective technologies for detecting viruses or biomarkers that indicate virus infection using nucleic acid amplification, antigen detection, and next-generation sequencing, as well as other germinating techniques that can be applied to the detection of emerging viruses.
Dr. Yohei Kurosaki
Dr. Danyelly Bruneska Gondim Martins
Dr. José Luiz Lima Filho
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- emerging virus
- molecular diagnostics
- nucleic acid amplification
- antigen detection
- next-generation sequencing
- variant detection
- outbreak preparedness